183 related articles for article (PubMed ID: 38182727)
1. Human leukocyte antigen-DQA1*04:01 and rs2040406 variants are associated with elevated risk of childhood Burkitt lymphoma.
Liu Z; Luo Y; Kirimunda S; Verboom M; Onabajo OO; Gouveia MH; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Dhudha H; Ayers LW; Bhatia K; Goedert JJ; Cole N; Luo W; Liu J; Manning M; Hicks B; Prokunina-Olsson L; Chagaluka G; Johnston WT; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Hsing AW; Mensah JE; Adjei AA; Hutchinson A; Carrington M; Yeager M; Blasczyk R; Chanock SJ; Raychaudhuri S; Mbulaiteye SM
Commun Biol; 2024 Jan; 7(1):41. PubMed ID: 38182727
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and
Liao HM; Liu H; Chin PJ; Li B; Hung GC; Tsai S; Otim I; Legason ID; Ogwang MD; Reynolds SJ; Kerchan P; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Ayers LW; Pfeiffer RM; Bhatia K; Goedert JJ; Lo SC; Mbulaiteye SM
Front Oncol; 2022; 12():812224. PubMed ID: 35340265
[TBL] [Abstract][Full Text] [Related]
3. Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda.
Kirimunda S; Verboom M; Otim I; Ssennono M; Legason ID; Nabalende H; Ogwang MD; Kerchan P; Kinyera T; Mwebaza I; Joloba M; Ayers LW; Reynolds SJ; Bhatia K; Onabajo OO; Hallensleben M; Biggar RJ; Prokunina-Olsson L; Goedert JJ; Blasczyk R; Mbulaiteye SM
Br J Haematol; 2020 May; 189(3):489-499. PubMed ID: 32072624
[TBL] [Abstract][Full Text] [Related]
4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
5. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.
Westmoreland KD; Montgomery ND; Stanley CC; El-Mallawany NK; Wasswa P; van der Gronde T; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Kampani C; Liomba NG; Tomoka T; Dhungel BM; Sanders MK; Krysiak R; Kazembe P; Dittmer DP; Fedoriw Y; Gopal S
Int J Cancer; 2017 Jun; 140(11):2509-2516. PubMed ID: 28268254
[TBL] [Abstract][Full Text] [Related]
6. HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome.
Adeyemo A; Esezobor C; Solarin A; Abeyagunawardena A; Kari JA; El Desoky S; Greenbaum LA; Kamel M; Kallash M; Silva C; Young A; Hunley TE; de Jesus-Gonzalez N; Srivastava T; Gbadegesin R
Am J Kidney Dis; 2018 Mar; 71(3):399-406. PubMed ID: 29277510
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen-DQ alleles and haplotypes and their associations with resistance and susceptibility to HIV-1 infection.
Hardie RA; Luo M; Bruneau B; Knight E; Nagelkerke NJ; Kimani J; Wachihi C; Ngugi EN; Plummer FA
AIDS; 2008 Apr; 22(7):807-16. PubMed ID: 18427198
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
[TBL] [Abstract][Full Text] [Related]
9. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
Avila-Carino J; Torsteinsdottir S; Bejarano MT; Klein G; Klein E; Masucci MG
Cell Immunol; 1988 Dec; 117(2):303-11. PubMed ID: 2848629
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
[TBL] [Abstract][Full Text] [Related]
12. HLA-DQA1 & DQB1 variants associated with hepatitis B virus-related chronic hepatitis, cirrhosis & hepatocellular carcinoma.
Karra VK; Chowdhury SJ; Ruttala R; Gumma PK; Polipalli SK; Chakravarti A; Kar P
Indian J Med Res; 2018 Jun; 147(6):573-580. PubMed ID: 30168489
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma.
Kaymaz Y; Oduor CI; Aydemir O; Luftig MA; Otieno JA; Ong'echa JM; Bailey JA; Moormann AM
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581102
[TBL] [Abstract][Full Text] [Related]
14. Association of human leukocyte antigen (HLA)-DQ and HLA-DQA1/DQB1 alleles with Vogt-Koyanagi-Harada disease: A systematic review and meta-analysis.
Liu B; Deng T; Zhu L; Zhong J
Medicine (Baltimore); 2018 Feb; 97(7):e9914. PubMed ID: 29443768
[TBL] [Abstract][Full Text] [Related]
15. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study.
Mutalima N; Molyneux E; Jaffe H; Kamiza S; Borgstein E; Mkandawire N; Liomba G; Batumba M; Lagos D; Gratrix F; Boshoff C; Casabonne D; Carpenter LM; Newton R
PLoS One; 2008 Jun; 3(6):e2505. PubMed ID: 18560562
[TBL] [Abstract][Full Text] [Related]
16. Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections.
Sallah N; Miley W; Labo N; Carstensen T; Fatumo S; Gurdasani D; Pollard MO; Dilthey AT; Mentzer AJ; Marshall V; Cornejo Castro EM; Pomilla C; Young EH; Asiki G; Hibberd ML; Sandhu M; Kellam P; Newton R; Whitby D; Barroso I
Nat Commun; 2020 Jul; 11(1):3849. PubMed ID: 32737300
[TBL] [Abstract][Full Text] [Related]
17. Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.
Kabyemera R; Masalu N; Rambau P; Kamugisha E; Kidenya B; De Rossi A; Petrara MR; Mwizamuholya D
BMC Pediatr; 2013 Jan; 13():4. PubMed ID: 23294539
[TBL] [Abstract][Full Text] [Related]
18. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
[TBL] [Abstract][Full Text] [Related]
19. Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma.
Minnicelli C; Barros MH; Klumb CE; Romano SO; Zalcberg IR; Hassan R
PLoS One; 2012; 7(9):e46005. PubMed ID: 23029361
[TBL] [Abstract][Full Text] [Related]
20. Burkitt's Lymphoma.
Rochford R; Moormann AM
Curr Top Microbiol Immunol; 2015; 390(Pt 1):267-85. PubMed ID: 26424650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
